| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.682 | 57.524 | 9.745 | 0 | 0 | 0 | - | - | - | - |
| Total Income - EUR | 29.739 | 57.839 | 11.059 | 0 | 0 | 1.736 | - | - | - | - |
| Total Expenses - EUR | 29.836 | 51.556 | 21.767 | 1.125 | 6.077 | 5.340 | - | - | - | - |
| Gross Profit/Loss - EUR | -97 | 6.284 | -10.708 | -1.125 | -6.077 | -3.604 | - | - | - | - |
| Net Profit/Loss - EUR | -989 | 5.546 | -10.818 | -1.125 | -6.077 | -3.615 | - | - | - | - |
| Employees | 0 | 1 | 0 | 1 | 1 | 0 | - | - | - | - |
Check the financial reports for the company - Timad Pharmacy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.994 | 1.503 | 4.781 | 4.672 | 4.582 | 4.495 | - | - | - | - |
| Current Assets | 11.580 | 12.551 | 3.434 | 3.186 | 1.315 | 287 | - | - | - | - |
| Inventories | 10.939 | 12.071 | 0 | 0 | 0 | 0 | - | - | - | - |
| Receivables | 0 | 0 | 3.419 | 0 | 0 | 0 | - | - | - | - |
| Cash | 641 | 480 | 15 | 3.186 | 1.315 | 287 | - | - | - | - |
| Shareholders Funds | -944 | 4.612 | -6.284 | -7.294 | -13.230 | -16.593 | - | - | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | 14.518 | 9.442 | 14.500 | 15.153 | 19.127 | 21.376 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Timad Pharmacy Srl